{
    "clinical_study": {
        "@rank": "136276", 
        "arm_group": {
            "arm_group_label": "Intubated", 
            "arm_group_type": "Experimental", 
            "description": "NAVA level from 0.1 to 3"
        }, 
        "brief_summary": {
            "textblock": "Neurally adjusted ventilatory assist (NAVA) is a mode of mechanical ventilation that uses\n      the diaphragm's normal electrical activity to deliver a mechanically supported breath.  The\n      amount of support provided is determined in part by the NAVA level, where a higher NAVA\n      level will provide higher level of support and unload more of the work of the diaphragm.\n      The purpose of this study is to compare the optimal NAVA level in neonates while on\n      mechanical ventilation while intubated and after being extubated."
        }, 
        "brief_title": "Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Other Specified Respiratory Problems in Fetus or Neonate", 
        "detailed_description": {
            "textblock": "Baseline measurements will be taken. The NAVA titration study will then be done. The NAVA\n      level will be set at a starting value of 0.1 cm H2O/mcV and systematically increased by 0.5\n      cm H2O/mcV every three minutes to a maximum of 3 cmH2O/mcV.  Once the NAVA titration study\n      has been completed, the patient will be extubated. There will be a stabilization period\n      following extubation (15-30 minutes), and then the NAVA titration study will be repeated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Neonates on NAVA ventilation\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Weeks", 
            "minimum_age": "23 Weeks"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02048280", 
            "org_study_id": "TCH02"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intubated", 
                "description": "Peak inspiratory pressure will be measured at each NAVA level", 
                "intervention_name": "NAVA level", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Intubated", 
                "description": "Increase NAVA level every 3 minutes", 
                "intervention_name": "NAVA level", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toledo", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43606"
                }, 
                "name": "Promedica Toledo CHildren's Hospital NICU"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support", 
        "overall_official": {
            "affiliation": "Promedica Toledo Childrne's Hospital", 
            "last_name": "Howard Stein, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "NAVA titration study will be done pre and post extubation to determine and then compare the breakpoint.", 
            "measure": "Changes in breakpoint in intubated and extubated patients", 
            "safety_issue": "No", 
            "time_frame": "20 minute study pre and post extubation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02048280"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "ProMedica Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ProMedica Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}